WS #11253

The dominant signal in this window is the escalation of the Strait of Hormuz crisis, with Europe acknowledging that increased shipping fees are now inevitable and reports that Iran is collecting tolls from ships. This is corroborated by multiple sources (Bluesky posts, Al Jazeera, OilPrice.com) and represents an escalation from the previous window's 'inevitable fees' framing. The US Navy blockade order and UK refusal to join add geopolitical risk. Separately, the US June payrolls miss (57K vs 113K expected) is being digested, with markets now pricing two Fed cuts by April 2027. Tesla's Q2 delivery beat (480K vs 406K est.) triggered a sell-the-news reaction with shares down ~7%, as the market focuses on margin concerns and BYD reclaiming the global EV sales crown. Rivian raised its 2026 delivery outlook, sending stock up 10%+. ClearOne shares surged 79% on a merger with Cortigent (Vivani Medical subsidiary). The Justice Department is probing alleged $100M insider trading ahead of a Chinese regulatory crackdown. Big Pharma stocks gained on news the Trump administration is considering cutting 340B drug discounts. Mortgage rates declined to 6.43%, a seven-week low. The narrative arc is: Hormuz crisis ESCALATING, growth scare STABLE, Tesla sell-the-news STABLE.